[144] Corvel Corp SEC Filing

Rhea-AI Filing Summary

CorVel Corp (CRVL) Form 144 notice: A holder intends to sell 40,000 shares of common stock through UBS Financial Services on the NASDAQ, with an aggregate market value reported as $3,555,773.00 and an approximate sale date of 09/02/2025. The shares were acquired as Founders Shares from the issuer on 05/01/1991 and the filer reports no securities sold in the past three months. The notice includes the standard representation that the seller does not possess undisclosed material adverse information. The filing provides broker details and basic transaction disclosure but no forward guidance, financial results, or additional context about the holder.

Positive

• None.

Negative

• Proposed sale size disclosed: 40,000 common shares with aggregate market value of $3,555,773.00 scheduled for 09/02/2025.
• Limited filer identification and context: The provided content does not include the filers CIK/CCC values or the filers explicit relationship to the issuer in the visible fields.

Insights

Securities Analyst

TL;DR: Routine Rule 144 filing disclosing a proposed sale of 40,000 founder shares valued at $3.56M to be executed via UBS on NASDAQ.

This Form 144 is a standard regulatory notice that allows a holder to publicly disclose an intended sale under Rule 144. The filing specifies the class, broker, number of shares, aggregate market value, original acquisition as founders shares in 1991, and the planned sale date. It does not contain information on the filers identity, motivations for sale, or any other securities transactions beyond noting "Nothing to Report" for the prior three months. On its face, the filing is informational and routine; its materiality depends on the holders overall ownership stake, which is not provided here.

Corporate Governance Specialist

TL;DR: Disclosure meets Rule 144 form requirements but lacks context on insider status and aggregate holdings.

The document fulfills the procedural requirements by listing broker, share quantity, market value, acquisition date and nature (founders shares). It includes the sellers attestation about lack of undisclosed material adverse information. However, the form omits the filers identifying CIK/CCC values in the provided content and does not state the filers relationship to the issuer beyond the acquisition line. From a governance perspective, investors must consult the full filing (including omitted identifying fields) or company filings for ownership context before assessing potential governance or signaling implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	40000	3555773.00	51312748	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/1991	Founders Shares	Issuer			40000	05/01/1991	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CorVel Corp (CRVL) Form 144 disclose?

The filing discloses an intended sale of 40,000 common shares through UBS on NASDAQ with aggregate market value of $3,555,773.00 and approximate sale date 09/02/2025.

When were the shares being sold originally acquired?

The shares were acquired on 05/01/1991 as Founders Shares from the issuer, per the filing.

Does the filing report other sales by this person in the past three months?

No. The section "Securities Sold During The Past 3 Months" states "Nothing to Report".

Which broker is handling the proposed sale?

UBS Financial Services Inc., 11 Madison Avenue, 4th Floor, New York, NY 10010 is listed as the broker in the filing.

Does the Form 144 include any claim about undisclosed material information?

Yes. The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.